Anti-common γ-chain antibody: One for all in GVHD

3Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Hechinger and colleagues investigate the efficacy of the blockade of the common γ-chain receptor (CD132) as a novel approach in the management of both acute and chronic graft-versus-host disease (GVHD).

Cite

CITATION STYLE

APA

Pérez-Simón, J. A. (2015, January 15). Anti-common γ-chain antibody: One for all in GVHD. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-12-610659

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free